Here is Eli Lilly's competitive edge in GLP-1 obesity drugs and Abbott's secondary play

Here is Eli Lilly's competitive edge in GLP-1 obesity drugs and Abbott's secondary play


Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.)



Source

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Health

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Only half of health insurer Cigna‘s clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company’s pharmacy benefits unit Evernorth has reached a deal with […]

Read More
Cardiac arrests on the job are rising and often fatal. Workers and employers are not prepared for the risk
Health

Cardiac arrests on the job are rising and often fatal. Workers and employers are not prepared for the risk

In January 2023, Buffalo Bills safety Damar Hamlin’s shocking collapse during an NFL Monday Night Football game due to cardiac arrest placed a high-profile spotlight on a concerning, and growing, statistic: each year, more than 10,000 people suffer from cardiac arrests in U.S. workplaces.   But unlike Hamlin, whose unique workplace allowed him to receive immediate […]

Read More
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Health

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight […]

Read More